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Abstract
Background: Cardiac rehabilitation has beneficial effects on morbidity and mortality in patients with coronary
artery disease, but is vastly underutilised and short-term improvements are often not sustained. Telerehabilitation
has the potential to overcome these barriers, but its superiority has not been convincingly demonstrated yet. This
may be due to insufficient focus on behavioural change and development of patients’ self-management skills.
Moreover, potentially beneficial communication methods, such as internet and video consultation, are rarely used.
We hypothesise that, when compared to centre-based cardiac rehabilitation, cardiac telerehabilitation using
evidence-based behavioural change strategies, modern communication methods and on-demand coaching will
result in improved self-management skills and sustainable behavioural change, which translates to higher physical
activity levels in a cost-effective way.
Methods: This randomised controlled trial compares cardiac telerehabilitation with centre-based cardiac rehabilitation in
patients with coronary artery disease. We randomise 300 patients entering cardiac rehabilitation to centre-based cardiac
rehabilitation (control group) or cardiac telerehabilitation (intervention group). The core component of the intervention
is a patient-centred web application, which enables patients to adjust rehabilitation goals, inspect training and physical
activity data, share data with other caregivers and to use video consultation. After six supervised training sessions, the
intervention group continues exercise training at home, wearing an accelerometer and heart rate monitor. In addition,
physical activity levels are assessed by the accelerometer for four days per week. Patients upload training and physical
activity data weekly and receive feedback through video consultation once a week. After completion of the
rehabilitation programme, on-demand coaching is performed when training adherence or physical activity levels decline
with 50% or more. The primary outcome measure is physical activity level, assessed at baseline, three months and
twelve months, and is calculated from accelerometer and heart rate data. Secondary outcome measures include physical
fitness, quality of life, anxiety and depression, patient empowerment, patient satisfaction and cost-effectiveness.
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Discussion: This study is one of the first studies evaluating effects and costs of a cardiac telerehabilitation intervention
comprising a combination of modern technology and evidence-based behavioural change strategies including relapse
prevention. We hypothesise that this intervention has superior effects on exercise behaviour without exceeding the costs
of a traditional centre-based intervention.
Trial registration: Netherlands Trial Register NTR5156. Registered 22 April 2015.
Keywords: Cardiac rehabilitation, Telerehabilitation, Behavioural change, Physical activity, Patient empowerment,
Cost-effectiveness
Background
Cardiac rehabilitation (CR) has proven beneficial effects
on morbidity and mortality, and is highly recommended
in clinical guidelines for patients with coronary artery dis-
ease (CAD) [1–4]. Unfortunately, CR is vastly underuti-
lised, due to low referral rates and patient-related factors
such as travelling distance, work, or social obligations
[5, 6]. In addition, improvements in lifestyle behaviour
are often not maintained over time. As such, physical
activity levels often decline after a successful rehabilita-
tion programme and a significant amount of patients
with CAD do not meet the targets for secondary pre-
vention of cardiovascular disease (lifestyle, risk factor
and therapeutic targets) [7–9].
Alternatives for current centre-based CR should not
only aim to improve uptake rates, but also to maintain
the beneficial effects in the long term. For this purpose,
it may be effective to shift (part of ) the rehabilitation
programme to the home environment, especially for pa-
tients who are unable to participate in conventional
centre-based CR due to transport difficulties or work re-
sumption. A meta-analysis showed no difference between
home-based and centre-based CR in mortality risk, cardiac
events, improvement of exercise capacity and modifiable
risk factors [10]. However, these home-based interventions
often lack long-term follow-up and applied varying moni-
toring strategies and training protocols in heterogeneous
study populations. Studies that do report long-term effects
showed inconsistent results. A study by Smith et al.
showed a decline in peakVO2 between one and six years
follow-up in both the home-based and hospital-based
group, but the rate of decline was significantly smaller in
the home-based group [11]. Dracup et al. showed a decline
in peakVO2 after an initial improvement in patients with
heart failure following a home-based walking programme
and resistance training [12]. A decline in functional per-
formance might be explained by the fact that these home-
based interventions did not primarily focus on behavioural
change or on development of self-management skills but
on exercise training. In fact, behavioural aspects such as
dietary intake and activity behaviour were not monitored.
A more comprehensive approach is provided by car-
diac telerehabilitation, which often incorporates multiple
components of CR and uses monitoring devices and re-
mote communication with patients to deliver CR outside
the hospital environment. Providing objective feedback
and allowing patients to track their own progress may
increase patients’ self-management skills and thus estab-
lish a sustainable behavioural change [13–15]. Two re-
cent systematic reviews reported that, compared to
centre-based CR, telerehabilitation resulted in fewer ad-
verse events and rehospitalisation, higher physical activity
levels, better adherence to physical activity guidelines, and
improved LDL-cholesterol and diastolic blood pressure
levels [16, 17]. However, two other systematic reviews
showed no differences in outcomes in mortality or modifi-
able risk factors [18, 19]. The majority of telerehabilitation
interventions for cardiac patients are telephone-based
interventions, while other methods of communication
(e.g. internet, video consultation and/or text messages)
may enhance the provision of objective feedback [20].
Furthermore, the effectiveness of internet-based behav-
ioural change interventions increases when one or more
multiple behaviour change techniques are applied [20, 21].
For instance, relapse prevention is a cognitive behavioural
strategy that can be used in (internet-based) behavioural
change interventions such as cardiac telerehabilitation.
Relapse prevention teaches an individual how to identify
and cope with situations in which the actual behaviour
deviates from the intended behaviour. It can be applied
to multiple treatment modules in telerehabilitation (e.g.
nutritional counselling, smoking cessation or physical
activity coaching). Other strategies include goal setting,
self-monitoring, provision of feedback, enhancement of
self-efficacy and motivational interviewing [22]. If these
techniques are implemented, we expect that they will
lead to a more sustainable improvement of cardiovas-
cular risk profiles.
We hypothesize that cardiac telerehabilitation using
modern communication methods and multiple evidence-
based behavioural change strategies including relapse pre-
vention, will result in improved self-management skills
and sustainable behavioural change. We expect this will
translate to a superior increase in physical activity levels
when compared to centre-based CR. Therefore, the ob-
jective of the SmartCare-CAD trial is to investigate
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whether cardiac telerehabilitation using modern technol-
ogy and multiple behavioural change strategies results in
better long-term physical activity levels than centre-based
CR in patients with CAD. For telerehabilitation, a perso-
nalised patient-centred web application is used, compris-
ing remote monitoring of exercise and physical activity
behaviour and on-demand video consultation. In addition,
both strategies will be compared with respect to physical
fitness, modifiable cardiovascular risk factors, quality of
life, anxiety and depression disorders, patient empower-
ment, patient satisfaction and cost effectiveness.
Methods
Study design
This study is designed as a monocentre randomised
controlled trial at Máxima Medical Centre Eindhoven/
Veldhoven, the Netherlands. Patients from both Máxima
Medical Centre and Catharina Hospital Eindhoven are in-
cluded in the trial. Three hundred patients with CAD en-
tering outpatient CR are randomly allocated to cardiac
telerehabilitation with home-based exercise training
(intervention group) or centre-based CR (control group).
All subjects are requested to provide written informed
consent before study entry. Data are collected at baseline
and after three, six, nine, and twelve months. The protocol
for this study was approved by the Institutional Review
Board of Máxima Medical Centre Veldhoven in the
Netherlands. The trial is registered at the Netherlands
Trial Registry (NTR) with registration number NTR5156.
A completed SPIRIT (Additional file 1: Standard Protocol
Items: Recommendations for Interventional Trials) dia-
gram can be found in Table 1.
Study population
Patients entering outpatient CR because of CAD are con-
sidered for participation; i.e., patients with stable CAD, an
acute coronary syndrome (with or without ST-segment ele-
vation) and/or after coronary revascularization (primary or
elective percutaneous coronary intervention (PCI) or cor-
onary artery bypass grafting (CABG)). Only patients re-
ferred to exercise training as a part of outpatient CR, based
on the individual needs assessment from the guidelines on
outpatient CR of the Dutch Society of Cardiology, are
asked to participate [23]. Eligible patients are at least 18
years old and have access to a personal computer with
Internet connectivity at home. Patients are required to
have a mobile phone with short message service (SMS)
functionality to login to the web application with two-
factor authentication. Patients that do not have a personal
computer can be provided with a tablet that has necessary
software pre-installed. Exclusion criteria are: 1) ventricular
arrhythmia or myocardial ischemia during low to moderate
exercise intensity as assessed by symptom limited exercise
testing at baseline; 2) heart failure NYHA (New York Heart
Association) class IV, and 3) comorbidity precluding exer-
cise training (e.g. orthopaedic, neurological or cognitive
conditions). A complete list of inclusion and exclusion
criteria is provided in Table 2.
Randomisation, blinding and treatment allocation
Patients are randomly allocated to the intervention or
control group after baseline measurements by the inves-
tigator using a computerised randomisation system in
the web-based database software Castor EDC (Castor
Electronic Data Capture, Ciwit BV, Amsterdam, The
Netherlands), in which block randomisation with vari-
able block size (4, 6 or 8) is applied. Randomisation is
stratified for gender and left ventricular ejection fraction
(LVEF ≤ 35% or LVEF > 35%) to ensure balance of the
treatment arms with respect to the combinations of the
prognostic variables. The investigator, supervising health-
care professionals and patients are not blinded for treat-
ment due to the nature of the intervention.
Sample size calculation
Adopted from Kraal et. al [24], we calculated sample size
for the primary outcome measure –physical activity en-
ergy expenditure (PAEE) – assuming PAEE in healthy sub-
jects was 4.0 ± 1.2 MJ/day [25]. If the difference in the
primary outcome measure between the intervention and
control groups is 10%, 143 subjects need to be included in
either group (power = 0.8 and alpha =0.05). Taking into
account loss to follow-up, 150 subjects are included in
both groups.
Exercise training programme
The CR programme may consist of the following super-
vised outpatient treatment modules: exercise training, an
information programme, a relaxation programme, a smok-
ing cessation programme, a psycho-educative prevention
programme and/or individual treatment by a psychologist
or dietician. Based on the individual needs assessment
procedure, one or more of these treatment modules are
selected [23]. Treatment goals and results of the needs as-
sessment are registered in the Hospital Information Sys-
tem by the nurse specialist. In both treatment groups, the
CR programme consists of at least the exercise training
module. The exercise training programme in both the
intervention and control group is composed according to
evidence-based clinical algorithms for the prescription
and evaluation of exercise-based CR [26]. These algo-
rithms serve as best practice standards in the Netherlands
and were developed using recent Dutch and European
CR guidelines and position statements. The content of
the programme is determined individually, based on the
referral diagnose, training goal(s) and physical fitness level.
The programme may consist of several training modal-
ities, including aerobic training (continuous training (CT)
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or high-intensity interval training (HIT)), functional train-
ing and resistance training. In aerobic training, the train-
ing frequency ranges from 2–5 sessions per week, lasting
20–60 min at 50–80% (CT) or 80–90% (HIT) of the heart
rate reserve (HRR). We expect aerobic training to be
similar in both treatment groups in terms of duration,
frequency and intensity.
Control group (centre-based cardiac rehabilitation)
Patients in the control group participate in group-based
training sessions at the outpatient clinic (group size varies
between 8 to 12 participants) under supervision of phys-
ical therapists and exercise specialists. All physical thera-
pists and exercise specialists involved in this trial are
specialised in CR and have been trained in motivational
Table 1 Completed SPIRIT diagram for SmartCare-CAD
* t1 = three months, t2 = six months, t3 = nine months, t4 = twelve months
** Three months
** Three months + nine months of on-demand coaching
**** Part of routine care and therefore assessed before informed consent
KVL-H Kwaliteit van Leven bij Hartpatiënten, GAD-7 Generalized Anxiety Disorder, PHQ Patient Health Questionnaire, PAM Patient Activation Measure, SBSQ-D Set
of Brief Screening Questions – Dutch, CQI Consumer Quality Index
Brouwers et al. BMC Cardiovascular Disorders  (2017) 17:46 Page 4 of 11
interviewing. Patients receive an individually tailored
training programme on a treadmill or an electromagnetic-
ally braked cycle ergometer. Therefore, the total number
of training sessions will vary among patients according to
the clinical algorithms [26]. The physical therapist docu-
ments training attendance. In the last training session, the
training programme is evaluated and patients are encour-
aged to continue physical activities at home. After 3
months, all treatment modules of the CR programme are
evaluated by a nurse specialist at the outpatient clinic.
Intervention group (cardiac telerehabilitation)
Web application
The core component of the study intervention is a secured,
personalised, patient-centred web application. Safety and
privacy are warranted by using encryption and signature
layers. This platform enables patients to:
- Register and adjust rehabilitation goals, training goals
and treatment modules
- Upload and review exercise training data
- Upload and review daily physical activity data
- Perform video consulting with physical therapists
- Permit relevant pre-specified caregivers (e.g. cardiologist,
psychologist, general practitioner or informal carers) to
have access to the abovementioned data.
After the randomisation procedure, patients select and
specify their treatment goals during the second part of
the intake procedure with the nurse specialist. These
goals will be registered in the web application by the pa-
tient and the investigator. During this meeting patients
are instructed to use the platform on their personal com-
puter, and to provide access to other caregivers. Patients
also receive a heart rate monitor (Mio Alpha, Physical En-
terprises Inc., Vancouver, British Columbia, Canada) and
accelerometer (ActiGraph wGT3x-BT, Actigraph LLC,
Pensacola, Florida, USA).
Exercise training
Patients in the intervention group start their CR
programme with six supervised training sessions in the
outpatient clinic, similar to patients in the control group.
During these sessions, they are instructed about (home-
based) training and training intensity, the use of their
heart rate monitor and accelerometer and the transfer of
data to the web application. In addition, patients are
counselled on the training modality (e.g. cycling, walking/
running) they prefer to incorporate in their exercise
programme at home.
After six training sessions, exercise training is transferred
to the home environment. Exercise training is continued in
the hospital when home-based training is considered un-
safe by the CR cardiologist or when the patient prefers to
continue training in the hospital. If exercise training is
transferred to the home environment, exercise training tar-
gets (i.e. frequency, session duration and time in heart rate
zone) and physical activity targets (time spent at a moder-
ate or high activity level, using a modified version of the al-
gorithm proposed by Sasaki et al. [27]) are recorded in the
web application. A weekly video consultation with the
physical therapist is scheduled until CR is completed and
evaluated at the outpatient clinic after three months. Dur-
ing these video consultations, both the exercise data and
physical activity data are evaluated and targets are adjusted
if needed.
If exercise training is not transferred to the home environ-
ment, patients continue exercise training at the outpatient
clinic. Similar to the control group, the total number of
training sessions is based on the clinical algorithms.
However, physical activity is monitored at home, using
data from the accelerometer. During the exercise training
sessions at the hospital, exercise and physical activity tar-
gets are evaluated, and adjusted in the web application if
needed.
Telemonitoring guidance
Patients are instructed to wear a wrist-worn heart rate
monitor with a display (Mio Alpha) and a hip-worn ac-
celerometer without a display (Actigraph wGT3x-BT)
during all training sessions. For exercise training sessions,
heart rate data is transferred to the accelerometer by
Bluetooth and stored locally. To assess physical activity
behaviour, patients are instructed to wear the acceler-
ometer four days a week during daytime, of which at
least one day during weekends. They upload exercise
Table 2 Inclusion and exclusion criteria for SmartCare-CAD
Inclusion criteria
i. Referral for cardiac rehabilitation due to stable angina pectoris,
acute coronary syndrome (with or without ST-segment elevation)
or after coronary revascularization, i.e. (primary or elective) PCI or
CABG
ii. Indication for exercise training as a part of outpatient cardiac
rehabilitation
iii. Personal computer with internet access at home
iv. Possession of a mobile phone with SMS-functionality
v. Age ≥18 years
vi. Able to speak, read and write Dutch
Exclusion criteria
i. Ventricular arrhythmia or myocardial ischemia during low to
moderate exercise intensity as assessed by symptom limited
exercise testing at baseline
ii. Heart failure NYHA class IV
iii. Comorbidity precluding exercise training (e.g. orthopaedic,
neurological or cognitive conditions)
PCI percutaneous coronary intervention, CABG coronary artery bypass grafting,
SMS Short Message Service, NYHA New York Heart Association
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training and physical activity data to the web applica-
tion weekly, by connecting the accelerometer to their
personal computer using a USB-connection. On the
web application, patients and their physical therapist
(as well as other people who have access to the plat-
form) can review the training and physical activity data
graphically. A weekly video consultation with the phys-
ical therapist takes place via the web application.
These consultations are based on semi-structured in-
terviews, in which the principles of motivational inter-
viewing are applied. Motivational Interviewing is a
psychosocial intervention technique to approach people
engaged in behavioural change and tries to expose am-
bivalence between current and future behaviour [28–30].
The goal of Motivational Interviewing is to increase pa-
tients’ intrinsic motivation and encourage self-efficacy, in
order to establish and maintain behavioural change.
During a video consultation, the physical therapist first
checks whether the training sessions lead to symptoms,
injuries or adverse events. Second, the physical therapist
verifies whether patients adhere to their training sched-
ule. Training frequency, session duration and intensity
are recorded on the web application and are evaluated
during the consultation. Together with the physical ther-
apist, patients can adjust their training schedule if a
structural problem prevents them from adhering to their
schedule. Third, the physical therapist and patient review
the physical activity data. They evaluate whether the
physical activity targets have been reached (i.e. a desired
amount of minutes spent at a moderate or high activity
level). During the video consultation, the physical therap-
ist identifies possible motivational issues, which can be ex-
posed and addressed using motivational interviewing. We
expect a video consult will take between 10 and 20 min.
Follow-up and on-demand coaching
During the final video consultation, the training period
is evaluated and the individual exercise and physical ac-
tivity targets are updated. These targets are recorded in
the web application. Patients are instructed to use the
heart rate monitor and accelerometer during the entire
study period and to upload exercise training and phys-
ical activity data to the web application every week.
After the evaluation of the CR programme, coaching is
performed on-demand. The web application evaluates the
exercise training and physical activity data every four weeks
and generates an alert in the following circumstances:
- Non-compliance: not uploading sensor data for ≥ 4 weeks.
- Reduced exercise training: a decrease of ≥ 50% in the time
spent in a specified heart rate zone (average per week)
- Reduced physical activity: a decrease of ≥ 50% in the
time spent in moderate to vigorous activity zone
(average per day).
If an alert is generated, a video consultation is sched-
uled. In this video consultation, exercise and physical ac-
tivity targets are evaluated and adjusted similarly to
previous video consultations. If the targets are adjusted,
the patient updates the targets in the web application.
Outcome measures
The primary outcome measure is physical activity level,
assessed at baseline, three months and twelve months.
Secondary outcome measures are physical fitness, Body
Mass Index (BMI), blood pressure, health related quality
of life, anxiety and depression and patient empowerment,
assessed at baseline and at three and twelve months.
Other secondary outcome measures include patient satis-
faction (assessed at twelve months) and cost-effectiveness
(assessed at three, six, nine and twelve months). Health lit-
eracy is only assessed at baseline. An overview of the study
design is provided in Fig. 1.
Measurements
Physical activity level
Physical activity level (PAL) is determined by physical
activity energy expenditure (PAEE), as described previ-
ously [31]. PAL is calculated from data from the acceler-
ometer (ActiGraph wGT3x-BT) and a chest-strap heart
rate monitor without a display (Polar H7, Polar Electro
Oy, Kempele, Finland). The data of the heart rate monitor
are transmitted to the accelerometer through Bluetooth.
Patients are required to wear the sensors during daytime
for an assessment period of four days, which includes two
weekend days. During these days, the wrist-worn heart
rate monitor (Mio Alpha) cannot be worn. Patients are
blinded for both physical activity (accelerometry) and
heart rate data.
After the assessment period of four days, patients in
the intervention group upload the data to the web appli-
cation. Patients in the control group return their sensors
to the investigator. Accelerometry data (40Hz sample
frequency) are synchronized with heart rate data (1Hz
sample frequency) and resampled into one minute epochs.
The energy expenditure estimation model developed by
Kraal et al. is applied to calculate PAL [31].
Physical fitness
Physical fitness is assessed by a symptom limited exercise
test. The maximal workload (in Watts) and percentage of
the predicted value are calculated after completion of the
test. The test will be performed on a cycle ergometer
(Lode Corrival, Groningen), using an individualised ramp
protocol aiming at a total test duration of 8–12 min. Pa-
tients are instructed to maintain a pedalling frequency of
70 rounds per minute. A twelve lead ECG is registered
continuously.
Brouwers et al. BMC Cardiovascular Disorders  (2017) 17:46 Page 6 of 11
Body mass index and blood pressure
The investigator measures length, weight and blood
pressure prior to the symptom limited exercise test.
Body mass index is defined as bodyweight divided by the
square of ones height (in kilograms per square metre).
Blood pressure is recorded using an automatic digital
sphygmomanometer, using a standard cuff size for an
arm circumference of 22–32 cm as well as an oversized
cuff for larger arm circumferences according to the
manufacturer's guidelines. Patients are instructed to
adopt an upright sitting posture with the right arm on a
table, the palm facing upwards, with uncrossed legs and
Fig. 1 Flowchart of the study design. KvL-H Kwaliteit van Leven bij Hartpatiënten, GAD-7 Generalized Anxiety Disorder, PHQ Patient Health
Questionnaire, PAM Patient Activation Measure, SBSQ-D Set of Brief Screening Questions - Dutch, CQI Consumer Quality Index
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the feet placed on the floor throughout the procedure.
The cuff is applied to the right upper arm so that the
bottom edge of the cuff is positioned 1–2 cm above the
elbow joint and the cuff at heart height. At least two
measurements are taken with a 5-min interval and the
second blood pressure reading is used in the data ana-
lysis [32].
Health-related quality of life
Health-related quality of life is assessed by the KvL-H
(Kwaliteit van Leven bij Hartpatiënten; quality of life in
cardiac patients) questionnaire, a validated Dutch trans-
lation of the MacNew heart disease health-related qual-
ity of life questionnaire [33]. The questionnaire provides
an overall score as well as scores on physical, emotional
and social domain scales.
Anxiety and depression
The GAD-7 (Generalized Anxiety Disorder) and PHQ-9
(Patient Health Questionnaire) are recommended by the
Dutch Society of Cardiology to screen CR patients for
anxiety and depression [23]. The GAD-7 is a validated
seven-item anxiety scale for the screening and assess-
ment of generalized anxiety disorder [34]. The PHQ-9 is
a 10-item multipurpose questionnaire for the screening
and assessment of depression [35].
Patient empowerment, patient satisfaction and health
literacy
Patient empowerment is assessed by the PAM13 (Patient
Activation Measure) questionnaire [36]. This 13-item
questionnaire was previously validated in the Dutch lan-
guage and assesses patients’ skills for self-management
of their health or chronic condition [37].
Patient satisfaction will be assessed by a modified ver-
sion of the Dutch Consumer Quality Index (CQI) for
rehabilitation medicine [38]. Health literacy is assessed
by the Dutch version of the Set of Brief Screening
Questions (SBSQ-D). This questionnaire consists of 3
questions with a 5-point Likert scale [39].
Cost-effectiveness
Both a cost-effectiveness analysis using PAL as effect
measure and a cost-utility analysis using quality adjusted
life years (QALYs) as outcome measure will be performed.
The economic evaluation assumes a societal perspective,
including both healthcare and non-healthcare related
direct and indirect costs [40, 41]. Healthcare related
costs include costs that are related to prevention, diagnos-
tics and treatment; e.g. visits to healthcare professionals
(outpatient visits, paramedical visits, general practitioner
visits), assessment (exercise testing), professional wages,
monitoring devices (accelerometer, heart rate monitor),
medication and hospitalizations. Non-healthcare related
costs include both costs made by the patient associated
with the treatment, e.g. travelling costs and costs related
to productivity loss due to absenteeism or presenteeism
(the costs for productivity loss due to health issues while
at work) in paid and unpaid work. Discounting in cost-
effectiveness will not be used due to the time frame of the
economic evaluation of one year.
Resource use in both treatment groups is prospectively
assessed during the clinical study. Prices published in
the Dutch Manual for Costing in economic evaluations
and market prices are used [42]. Other costs are mea-
sured using the modified iMCQ (Medical Consumption
Questionnaire) and iPCQ (Productivity Cost Question-
naire) questionnaires [40, 41], which patients fill out at
three, six, nine and twelve months. To assess the effects
of the delivery of informal care and to include these in
the economic evaluation, informal carers of patients fill
out the minimum variant of the iVICQ (Valuation of In-
formal Care Questionnaire) at three, six, nine and twelve
months [43]. Either the friction cost method or the hu-
man capital approach is applied to determine the costs
of absenteeism or inefficiency from paid work [44].
In the cost-effectiveness analysis, PAL is used as effect
measure. In the cost-utility analysis, QALYs are mea-
sured using the EQ-5D-5L questionnaire at three, six,
nine and twelve months [45].
Statistical analysis
All analyses will be performed on an intention-to-treat
basis. Descriptive statistics will be used to report demo-
graphics and baseline characteristics. Between-group dif-
ferences and within group differences in the outcome
measures will be evaluated using multivariate analysis of
variance (MANOVA). Pearson’s correlation coefficient
(r) will be applied to quantify relations between changes
in variables. For all statistical comparisons, the level of
significance will be set at p < 0.05. Analyses will be carried
out in the statistical software package SPSS (version 22).
Trial status
The Institutional Review Board of the hospital has ap-
proved the study protocol and its amendments prior to
the start of the study. The inclusion of patients has
started in May 2016 and is expected to be completed in
September 2017.
Discussion
The SmartCare-CAD trial is one of the first studies
evaluating the effects and costs of a cardiac telerehabil-
itation intervention that combines modern technology
(internet, sensor technology and video consultation) with
evidence-based behavioural change strategies, including
relapse prevention by on-demand coaching. The object-
ive of this study is to investigate whether cardiac
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telerehabilitation using modern technology and multiple
behavioural change strategies results in better long-term
physical activity levels than centre-based CR in patients
with CAD. We hypothesise that this intervention will re-
sult in improved self-management skills and a sustain-
able change in behaviour. This will translate to a
superior increase in physical activity levels when com-
pared to centre-based CR.
Based on the literature, it is still unclear how cardiac tel-
erehabilitation compares to centre-based CR. Internet-
based interventions may improve the efficacy of CR and
can reach the majority of patients, with 81% of households
in the European Union Member States – and 96% in the
Netherlands – having internet access at home [46]. How-
ever, evidence to support internet-based delivery of CR is
scarce [47, 48]. From the small amount of randomised
controlled trials evaluating internet-based delivery of CR,
only a few compare their intervention with centre-based
CR [49–51].
Our study distinguishes itself from other studies by the
use of modern communication technologies (internet, video
consultation), relapse prevention by on-demand coaching,
and coaching on both objective training intensity and phys-
ical activity. The assessment of both training intensity and
physical activity in the home environment allows for indi-
vidually tailored coaching for every patient for both compo-
nents of the exercise program, instead of focusing on just
one. Using the internet and video consultation may further
enhance the effectiveness of the intervention [20]. Another
important aspect of our study is the objective assessment of
physical activity. As physical inactivity increases overall mor-
bidity and mortality [52], an active lifestyle is considered as
an important goal in CR. It is frequently reported in clinical
studies, but often not objectively measured. Objectively
measuring physical activity (or PAL) using accelerometer
and heart rate data is more reliable than using question-
naires for self-reported physical activity [53], which enables
an accurate assessment of the primary outcome measure.
Although a cost-effectiveness analysis is essential for the
implementation of a novel intervention, only few cardiac
telerehabilitation studies have performed such an analysis.
A study by Frederix et al. showed that a prolonged,
internet-based comprehensive telerehabilitation programme
in addition to conventional CR was cost-effective [54].
Kidholm et al. however found that a cardiac telerehabilita-
tion programme as an alternative to centre-based CR was
not cost-effective [55]. In the SmartCare-CAD study, we
will perform a comprehensive cost-effectiveness analysis,
also taking into account productivity losses in paid and
unpaid work due to health issues.
Limitations
This study has a number of limitations. First, both the
control and intervention group may be heterogeneous
with respect to training frequency and intensity, since
the number of training sessions will vary among pa-
tients, based on the aforementioned clinical algorithms
[26]. Especially within the intervention group, variation
may arise when patients do not transfer exercise training
to the home environment during the first 3 months due
to safety issues or patient preferences. However, these
patients have access to the web application and will re-
ceive on-demand coaching from three months onwards.
It is unknown to which extent this variation within both
groups affects our outcome measures. Yet, we have
chosen this study design since it best reflects clinical prac-
tice when such an intervention would be implemented.
Besides, this variation is unavoidable because a patient’s
CR programme should be determined individually based
on the individual patient and disease characteristics [26].
Second, due to the Hawthorne effect, we expect patients
to be more physically active on the days they wear sensors
for the physical activity assessment. We expect that the ef-
fect does not impair the comparison of physical activity
levels between groups to a great extent, because the Haw-
thorne effect is expected in both groups.
Conclusion
The SmartCare-CAD study will provide new insights in
the effects of internet-based cardiac telerehabilitation. It
will address the added value of modern methods of com-
munication, such as a patient-centred web application
and videoconferencing. Besides, it will evaluate the effects
of relapse prevention by on-demand coaching, both for
coaching of exercise training and physical activity. Finally,
it enables a direct and comprehensive cost-effectiveness
analysis of cardiac telerehabilitation compared to centre-
based CR.
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